BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26526193)

  • 1. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay].
    Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
    de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
    Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
    J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.
    Chen L; Zhang Y; Zhang S; Chen Y; Shu X; Lai J; Cao H; Lian Y; Stamataki Z; Huang Y
    Arch Virol; 2019 Feb; 164(2):483-495. PubMed ID: 30415392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rational approach to select immunogenic peptides that induce IFN-γ response against Toxoplasma gondii in human leukocytes.
    Cardona NI; Moncada DM; Gómez-Marin JE
    Immunobiology; 2015 Dec; 220(12):1337-42. PubMed ID: 26210043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay.
    Chen C; Jiang X; Liu X; Guo L; Wang W; Gu S; Wen C; Yi X; Tang L; Li Y
    J Leukoc Biol; 2021 Feb; 109(2):455-465. PubMed ID: 32620046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.
    Malmassari S; Lone YC; Zhang M; Transy C; Michel ML
    Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunodominant HLA-A*1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients.
    Chen X; Wang W; Wang S; Meng G; Zhang M; Ni B; Wu Y; Wang L
    J Gen Virol; 2013 Dec; 94(Pt 12):2717-2723. PubMed ID: 23997182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and Identification of HBV Epitopes Restricted by Multiple Prevalent HLA-A Allotypes.
    Ding Y; Zhou Z; Li X; Zhao C; Jin X; Liu X; Wu Y; Mei X; Li J; Qiu J; Shen C
    Front Immunol; 2022; 13():847105. PubMed ID: 35464415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of antiviral therapy on virus-specific T-cell reactivity in patients with chronic hepatitis B].
    Feng X; Yan HP; Liao HY; Liu YM; Huang YL; Zhang GY; Lin F; Zhang X; Zhao Y; Zhang HP; Wang S; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):739-42. PubMed ID: 22781352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune responses to the hepatitis B virus polymerase.
    Mizukoshi E; Sidney J; Livingston B; Ghany M; Hoofnagle JH; Sette A; Rehermann B
    J Immunol; 2004 Nov; 173(9):5863-71. PubMed ID: 15494540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
    Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
    Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
    J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation--an insight from human immunodeficiency virus/hepatitis B virus coinfection.
    Mondal RK; Khatun M; Ghosh S; Banerjee P; Datta S; Sarkar S; Saha B; Santra A; Banerjee S; Chowdhury A; Datta S
    Clin Microbiol Infect; 2015 Jul; 21(7):710.e11-20. PubMed ID: 25882358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.